FDA Structure and U.S. Regulatory Oversight Details
1 report, 1 independent
Updated Sep 1
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The Food and Drug Administration (FDA) operates as a regulatory agency whose authority is formally derived from the United States government. The FDA includes the Center for Devices and Radiological Health as a formal division. Furthermore, the FDA appoints individuals to formal leadership roles, such as the Commissioner, which is currently held by Tukaram Mundhe.
From edaily.co.kr
Why it matters
The FDA's structure includes specialized bodies like the Center for Devices and Radiological Health which issues alerts and holds meetings under its designation. The agency's existence and operational scope are formally tied to the government of the United States of America.
From edaily.co.kr
Who's involved
- FDAU.S. regulatory agency responsible for product approval and market oversight
- Center for Devices and Radiological HealthFormal division of the FDA that issues alerts and holds meetings
- United States of AmericaGovernmental entity from which the FDA derives its authority
- Heidi OvertonIndividual appointed to the formal leadership role of the FDA Commissioner
- Tukaram MundheIndividual holding the formal position of FDA Commissioner
Keep exploring
The entities involved
Related events
- Cardiol Therapeutics Inc. is listed on Nasdaq and is developing therapy for an FDA-approved indication.
- Iovance Biotherapeutics received FDA approval for its therapy, and the company is listed on Nasdaq.
- A product was launched in the U.S. market following FDA involvement.
- Decoy Therapeutics is listed on the Nasdaq stock exchange and is currently seeking expedited regulatory approval via FDA pathways.
- Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.